It is an australian company--metabolic pharmaceuticals ltd. I agree that, if the FDA approves it, it will be a prescription drug. The company contracted to make the medication, Bresagen, should also be a good investment. Remember, virtually no country's research meets the demands of the FDA--that is why we are so far behind the rest of the world.